PETER F DRAKE Insider Trading
Get free email notifications about insider trading for PETER F DRAKE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER F DRAKE. PETER F DRAKE is a Director in RespireRx Pharmaceuticals Inc. ($RSPI) and a Director in NAVIDEA BIOPHARMACEUTICALS, INC. ($NAVB) and a 10% Owner in Trevi Therapeutics, Inc. ($TRVI).
Address: 15241 BARRANCA PKWY IRVINE 92618 CA
Companies in which PETER F DRAKE is an Insider
NAVIDEA BIOPHARMACEUTICALS, INC.
Trading Symbol: NAVBIndustry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of PETER F DRAKE: Director
Holdings: 77,829 shares
Current Value: $40,471
Latest Transaction: Jul 21 2015
$NAVB Market Capitalization: $77.59M
$NAVB Previous Close: $0.52
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RespireRx Pharmaceuticals Inc.
Trading Symbol: RSPIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PETER F DRAKE: Director
Holdings: 50,000 shares
Current Value: $195,000
Latest Transaction: Aug 07 2012
$RSPI Market Capitalization: $7.87M
$RSPI Previous Close: $3.90
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Trevi Therapeutics, Inc.
Trading Symbol: TRVIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of PETER F DRAKE: 10% Owner
Holdings: 62,540 shares
Latest Transaction: May 13 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of PETER F DRAKE
Sentiment: All, NAVB, RSPI, TRVI
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 13 2019 | TRVI | Trevi Therapeutics ... | DRAKE PETER F | 10% Owner | Option Exercise | C | 0.00 | 376,023 | 0 | 0 | |
May 13 2019 | TRVI | Trevi Therapeutics ... | DRAKE PETER F | 10% Owner | Option Exercise | C | 0.00 | 133,153 | 0 | 0 | |
May 13 2019 | TRVI | Trevi Therapeutics ... | DRAKE PETER F | 10% Owner | Buy | C | 0.00 | 62,540 | 0 | 62,540 | 0 to 62.5 K |
Jul 21 2015 | NAVB | NAVIDEA BIOPHARMAC ... | DRAKE PETER F | Director | Sell | D | 0.01 | 22,000 | 220 | 77,829 | 99.8 K to 77.8 K (-22.04 %) |
Mar 30 2015 | NAVB | NAVIDEA BIOPHARMAC ... | DRAKE PETER F | Director | Grant | A | 0.00 | 22,000 | 0 | 99,839 | 77.8 K to 99.8 K (+28.26 %) |
Aug 07 2012 | RSPI | RespireRx Pharmace ... | DRAKE PETER F | Director | Option Exercise | A | 0.06 | 346,667 | 20,800 | 376,667 | |
Aug 07 2012 | RSPI | RespireRx Pharmace ... | DRAKE PETER F | Director | Option Exercise | A | 0.06 | 30,000 | 1,800 | 30,000 |